Advanced Allergology: Hymenoptera Venom Allergy and Anaphylaxis — Scientific-Academic Guide

Allergology and Immunology · Clinical Specialties

How it begins

Un análisis exhaustivo y pormenorizado de la proteómica, la inmunopatología de la degranulación de mastocitos y basófilos, las directrices mundiales de diagnóstico de precisión y los algoritmos terapéuticos contemporáneos de la inmunoterapia y el shock anafiláctico.

What it covers

1. Hymenoptera Allergy and Anaphylaxis
2. Taxonomy and Biology of Hymenoptera
3. · Families and Species of Allergological Importance
4. Venom Proteomics and Biochemistry
5. · Major and Minor Allergens of Apis mellifera and Vespidae
6. Immunopathology of IgE-Mediated Allergy
7. · The Immune Sensitization Phase
8. · Effector Phase: Intracellular Signaling and Degranulation
9. · Preformed and De Novo Synthesis Mediators
10. Epidemiology, Risk Factors and Associated Comorbidities
11. · Severity and Lethality Risk Factors
12. Clinical Classification of Reactions by Hymenoptera
13. · 1. Local Reactions and Large Local Reactions (LLRs)
14. · 2. Systemic Allergic Reactions: Severity Scales
15. Multisystemic Pathophysiology of Anaphylaxis
16. · Mechanics of Hemodynamic Collapse: Distributive and Cardiogenic Shock
17. Precision Diagnosis of Poison Allergy
18. · 1. Skin Tests: Prick Test and Intradermorreaction (ID)
19. · 2. Precision In Vitro Diagnostics: Component-Resolved Diagnostics (CRD)
20. The Basophil Activation Test (BAT)
21. · Cytometric Fundamentals of Activation
22. · Specific Clinical Indications of BAT
23. Treatment of Acute Anaphylaxis
24. · Multireceptor Pharmacodynamic Mechanism of Adrenaline
25. Management of Refractory Anaphylaxis and Critical Support
26. · Critical Support and Hemodynamic Resuscitation Algorithm
27. · Advanced Airway Control under Laryngeal Angioedema
28. Immunotherapy with Hymenoptera Venom (VIT): Selection Criteria
29. · Indications for VIT according to Severity and Immunology
30. · Contraindications of Immunotherapy
31. VIT Induction Protocols
32. · VIT Induction Schemes
33. Maintenance, Effectiveness Monitoring and Termination of VIT
34. · Guidelines for Extending Maintenance Intervals
35. · Criteria for Cessation of VIT after 5 Years
36. Prescription of Adrenaline Autoinjectors and Emergency Plans
37. · Double Prescription Criteria for Autoinjectors (Two Devices)